Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04725981
Other study ID # BASEC-Nr.2018-00777
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date August 23, 2018
Est. completion date September 30, 2022

Study information

Verified date October 2022
Source Spital Limmattal Schlieren
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparing two surgical techniques in relation to vaginal stump infection, analysis of patient-based and therapy-based risk factors.


Description:

Comparing two surgical techniques for vaginal stump infection after total laparoscopic or robot-assisted hysterectomy. Analysis of patient-based and therapy-based risk factors with the aim of optimizing the surgical technique and objectifying the risk factors. Control group: old colpotomy technique (3 Z-sutures PDS 0); Intervention group: new colpotomy technique (3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0)


Recruitment information / eligibility

Status Terminated
Enrollment 141
Est. completion date September 30, 2022
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Patient > = 18 years old 2. Indication for total laparoscopic or robot-assisted hysterectomy 3. Benign uterine disease 4. Signed informed consent for study participation Exclusion Criteria: 1. Patient with malignant gynecological diseases 2. Combination with other abdominal / vaginal interventions, except: - Adhesiolysis - Endometriosis removal (without rectovaginal endometriosis) - Conization - Hysteroscopy / curettage 3. Immunosuppressive therapy with cytostatics, glucocorticoids, HIV 4. Bleeding tendency / haemophilia 5. Acute infection

Study Design


Intervention

Procedure:
Total laparoscopic hysterectomy
Control group: colpotomy closure technique: 3 Z-sutures PDS 0 Intervention group: colpotomy closure technique: 3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0

Locations

Country Name City State
Switzerland Spital Limmattal Schlieren Kanton Zurich

Sponsors (2)

Lead Sponsor Collaborator
Spital Limmattal Schlieren University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with vaginal stump infection in intervention group and control group 7.-10. day and 6 weeks postoperatively:
T ° C (fever> = 38 ° C)
blood pressure (mm Hg)
general condition (good, reduced, bad)
Speculum examination / condition of the colpotomy:
non-irritating / intact
dehiscent
bleeding
fibrin-coated
purulent
tender
hyperemic
Infiltrated
Fistula formation
Lower abdominal pain (Visual Analog Scale (VAS): 0-10
transvaginal sonography: encapsulated RF on vaginal stump J: ?N: ?
Laboratory CRP (> 10mg / L) Hb (<120 g / L) Lc ( >10 G / L)
The diagnosis of vaginal stump infection was made based on 2 of 3 positive clinical symptoms, 1 additional criterion and the corresponding sonographic findings.
I. Clinical symptoms: 1. Fever> = 38 ° C; 2. Dolence, redness, swelling, pus in the colpotomy area; 3. Lower abdominal pain ( VAS >5) II. Sonographic signs (TVUS): encapsulated cystic mass on the vaginal stump Additional criteria: 1. CRP increased (> 10mg / l); 2. Antibiotic therapy needs
6 weeks
Secondary Identify of patient-based and treatment-based risk factors for vaginal stump infection. connection between Obesity ( BMI >30 kg/ m2), nicotine abuse ( >5 cigarettes/d), anemia ( Hb <120g/L), operation time ( >120min), uterine volume ( >100 cm3) and appearance of vaginal stump infection 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT00324246 - Feasibility Study of the NEW NORMA-SENSE Phase 3
Recruiting NCT05021315 - Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection Phase 3
Not yet recruiting NCT05997160 - Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
Recruiting NCT05557318 - Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge N/A
Completed NCT05044156 - Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
Completed NCT00694928 - Vaginal Infection Study 2 Phase 3
Not yet recruiting NCT05590195 - Effect of PreforPro® on Urinary and Vaginal Health Phase 3
Completed NCT03898726 - Laparoscopic Versus Transvaginal Cuff Closure N/A
Withdrawn NCT01542606 - Performance Proof of Product Developed to Detect Abnormal Vaginal pH N/A
Not yet recruiting NCT05806879 - Impact of Maternity Napkins on the Incidence of Vaginal Infections in the Post-partum Period N/A
Completed NCT02308046 - Multi-Center Study of New Medications to Treat Vaginal Infections Phase 3
Completed NCT02308007 - Multi-Center Study of New Medications to Treat Vaginal Infections Phase 3
Completed NCT02308033 - Multi-Center Study of New Medications to Treat Vaginal Infections Phase 3
Completed NCT01599416 - Influence of U-relax on Vaginal Health Promotion and HPV DNA Test Change From Positive to Negative N/A
Recruiting NCT04719754 - Epidemiology of Abnormal Vaginal Discharge During Pregnancy
Completed NCT03261804 - Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users
Completed NCT03008421 - Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy N/A
Terminated NCT05788991 - Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis Phase 4
Completed NCT01843166 - Vaginal Estrogen With Pessary Treatment N/A
Not yet recruiting NCT03532464 - Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection Phase 4